Regulations.gov document
Transcript from the FDA/AASLD Workshop re Trial Designs and Endpoints for Liver Disease…
Supporting & Related Material · FDA-2013-N-0001 · posted Oct 21, 2014
Key facts
| Document ID | FDA-2013-N-0001-0134 |
|---|---|
| Title | Transcript from the FDA/AASLD Workshop re Trial Designs and Endpoints for Liver Disease Secondary to non Alcoholic Fatty Liver Disease (NAFLD) Day One Thursday, September 5, 2013 re FDA-2013-N-0001-0067 |
| Document type | Supporting & Related Material |
| Subtype | Transcript |
| Agency | FDA |
| Docket | FDA-2013-N-0001 |
| Posted | Oct 21, 2014 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: